Clinicopathological features of hepatosplenic T cell lymphoma: a single centre experience from India

References

• Jaffe ES, Harris NL, Stein H, . Introduction and overview of the classification of lymphoid neoplasms. In:Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J &Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International agency for research on Cancer; 2008. pp. 158–166.
   Google Scholar
• Naresh KN, Srinivas V, Soman CS. Distribution of various subtypes of non-Hodgkin's lymphoma in India: a study of 2773 lymphomas using R.E.A.L. and WHO Classifications. Ann Oncol 2000;11 Suppl 1:63–67.
   Google Scholar
• Sahni CS, Desai SB. Distribution and clinicopathologic characteristics of non-Hodgkin's lymphoma in India: a study of 935 cases using WHO classification of lymphoid neoplasms (2000). Leuk Lymphoma 2007;48:122–133.
   PubMed Web of Science ®Google Scholar
• Gaulard P, Jaffe ES, Krenacs L, . Hepatosplenic T cell lymphoma. In:Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, & Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: International agency for research on Cancer. pp. 292–293.
   Google Scholar
• Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000;14:991–997.
   PubMed Web of Science ®Google Scholar
• Vega F, Medeiros LJ, Bueso-Ramos C, . Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features. Am J Clin Pathol 2001;116:410–419.
   PubMed Web of Science ®Google Scholar
• Belhadj K, Reyes F, Farcet J-P, . Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood 2003;102:4261–4269.
   PubMed Web of Science ®Google Scholar
• Tripodo C, Iannitto E, Florena AM, . Gamma-delta T-cell lymphomas. Nat Rev Clin Oncol 2009;6:707–717.
   PubMed Web of Science ®Google Scholar
• Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111:3941–3967.
   PubMed Web of Science ®Google Scholar
• Borowitz MJ, Bray R, Gascoyne R, . U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data analysis and interpretation. Cytometry 1997;30:236–244.
   PubMedGoogle Scholar
• Korf BR. Overview of clinical cytogenetics. Curr Protoc Hum Genet 2001; Chapter 8: Unit 8.1.
   PubMedGoogle Scholar
• Roden AC, Morice WG, Hanson CA. Immunophenotypic attributes of benign peripheral blood gammadelta T cells and conditions associated with their increase. Arch Pathol Lab Med 2008; 132:1774–1780.
   PubMed Web of Science ®Google Scholar
• Falchook GS, Vega F, Dang NH, . Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment. Ann Oncol 2009;20:1080–1085.
   PubMed Web of Science ®Google Scholar
• Przybylski GK, Wu H, Macon WR, . Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn 2000;2:11–19.
   PubMed Web of Science ®Google Scholar
• Vega F, Medeiros LJ, Gaulard P. Hepatosplenic and other gammadelta T-cell lymphomas. Am J Clin Pathol 2007;127:869–880.
   PubMed Web of Science ®Google Scholar
• Cady FM, Morice WG. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders. Clin Lab Med 2007;27:513–532, vi.
   PubMed Web of Science ®Google Scholar
• Macon WR, Levy NB, Kurtin PJ, . Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas. Am J Surg Pathol 2001; 25:285–296.
   PubMed Web of Science ®Google Scholar
• Sandberg Y, Almeida J, Gonzalez M, . TCRgammadelta + large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRgammadelta + T-cells. Leukemia 2006;20:505–513.
   PubMed Web of Science ®Google Scholar
• O'Malley DP. T-cell large granular leukemia and related proliferations. Am J Clin Pathol 2007;127:850–859.
   PubMed Web of Science ®Google Scholar
• Rizzo K, Stetler-Stevenson M, Wilson W, . Novel CD19 expression in a peripheral T cell lymphoma: A flow cytometry case report with morphologic correlation. Cytometry B Clin Cytom 2009;76: 142–149.
   PubMed Web of Science ®Google Scholar
• van Dongen JJM, Langerak AW, Brüggemann M, . Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• Alonsozana EL, Stamberg J, Kumar D, . Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma. Leukemia 1997;11:1367–1372.
   PubMed Web of Science ®Google Scholar
• Wlodarska I, Martin-Garcia N, Achten R, . Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 2002;33:243–251.
   PubMed Web of Science ®Google Scholar
• Shetty S, Mansoor A, Roland B. Ring chromosome 7 with amplification of 7q sequences in a pediatric case of hepatosplenic T-cell lymphoma. Cancer Genet Cytogenet 2006;167:161–163.
   PubMed Web of Science ®Google Scholar
• Tamaska J, Adam E, Kozma A, . Hepatosplenic gammadelta T-cell lymphoma with ring chromosome 7, an isochromosome 7q equivalent clonal chromosomal aberration. Virchows Arch 2006;449: 479–483.
   PubMed Web of Science ®Google Scholar
• Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124–4130.
   PubMed Web of Science ®Google Scholar
• Davis BH, Holden JT, Bene MC, . 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytometry B Clin Cytom 2007;72 Suppl 1:S5–S13.
   PubMed Web of Science ®Google Scholar